Identification of the hydrophobic ligand binding pocket of the S1P1 receptor

被引:52
作者
Fujiwara, Yuko
Osborne, Daniel A.
Walker, Michelle D.
Wang, De-an
Bautista, Debra A.
Liliom, Karoly
Van Brocklyn, James R.
Parrill, Abby L.
Tigyi, Gabor
机构
[1] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA
[2] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA
[3] Univ Memphis, Computat Res Mat Inst, Memphis, TN 38152 USA
[4] Eastern Kentucky Univ, Dept Chem, Richmond, KY 40475 USA
[5] Ohio State Univ, Dept Pathol, Columbus, OH 43250 USA
[6] Hungarian Acad Sci, Inst Enzymol, Budapest, Hungary
关键词
D O I
10.1074/jbc.M609648200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Sphingosine 1-phosphate (S1P), a naturally occurring sphingolipid mediator and also a second messenger with growth factor-like actions in almost every cell type, is an endogenous ligand of five G protein-coupled receptors (GPCRs) in the endothelial differentiation gene family. The lack of GPCR crystal structures sets serious limitations to rational drug design and in silico searches for subtype-selective ligands. Here we report on the experimental validation of a computational model of the ligand binding pocket of the S1P(1) GPCR surrounding the aliphatic portion of S1P. The extensive mutagenesis-based validation confirmed 18 residues lining the hydrophobic ligand binding pocket, which, combined with the previously validated three head group-interacting residues, now complete the mapping of the S1P ligand recognition site. We identified six mutants (L3.43G/L3.44G, L3.43E/L3.44E, L5.52A, F5.48G, V6.40L, and F6.44G) that maintained wild type [P-32]S1P binding with abolished ligand-dependent activation by S1P. These data suggest a role for these amino acids in the conformational transition of S1P(1) to its activated state. Three aromatic mutations (F5.48Y, F6.44G, and W6.48A) result in differential activation, by S1P or SEW2871, indicating that structural differences between the two agonists can partially compensate for differences in the amino acid side chain. The now validated ligand binding pocket provided us with a pharmacophore model, which was used for in silico screening of the NCI, National Institutes of Health, Developmental Therapeutics chemical library, leading to the identification of two novel nonlipid agonists of S1P(1).
引用
收藏
页码:2374 / 2385
页数:12
相关论文
共 45 条
[1]
Ballasteros J. A., 1995, Methods in neurosciences, V25, P366
[2]
Dynamic modeling of EDG1 receptor structural changes induced by site-directed mutations [J].
Bautista, DL ;
Baker, DL ;
Wang, D ;
Fischer, DJ ;
Van Brocklyn, J ;
Spiegel, S ;
Tigyi, G ;
Parrill, AL .
JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 2000, 529 :219-224
[3]
CCK-B/gastrin receptor transmembrane domain mutations selectively alter synthetic agonist efficacy without affecting the activity of endogenous peptides [J].
Bläker, M ;
Ren, Y ;
Seshadri, L ;
McBride, EW ;
Beinborn, M ;
Kopin, AS .
MOLECULAR PHARMACOLOGY, 2000, 58 (02) :399-406
[4]
FTY720: Sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function [J].
Brinkmann, V ;
Cyster, JG ;
Hla, T .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (07) :1019-1025
[5]
FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity [J].
Brinkmann, V ;
Lynch, KR .
CURRENT OPINION IN IMMUNOLOGY, 2002, 14 (05) :569-575
[6]
FTY720: Altered lymphocyte traffic results in allograft protection. [J].
Brinkmann, V ;
Pinschewer, DD ;
Feng, L ;
Chen, S .
TRANSPLANTATION, 2001, 72 (05) :764-769
[7]
BUENEMANN M, 1996, EMBO J, V15, P5524
[8]
Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference [J].
Chae, SS ;
Paik, JH ;
Furneaux, H ;
Hla, T .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (08) :1082-1089
[9]
International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature [J].
Chun, J ;
Goetzl, EJ ;
Hla, T ;
Igarashi, Y ;
Lynch, KR ;
Moolenaar, W ;
Pyne, S ;
Tigyi, G .
PHARMACOLOGICAL REVIEWS, 2002, 54 (02) :265-269
[10]
Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone [J].
Cinamon, G ;
Matloubian, M ;
Lesneski, MJ ;
Xu, Y ;
Low, C ;
Lu, T ;
Proia, RL ;
Cyster, JG .
NATURE IMMUNOLOGY, 2004, 5 (07) :713-720